Illumina News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

04.11.22	Form 10-Q 1110803 (RSS)
03.11.22	Illumina Q3 Profit Beats Street View, But Cuts FY Outlook (RTTNews)
03.11.22	Form 8-K 1110803 (RSS)
02.11.22	ANAVASI DIAGNOSTICS ANNOUNCES NEWLY ELECTED OUTSIDE BOARD OF DIRECTORS (PR Newswire)
17.10.22	Initial statement of beneficial ownership of securities (RSS)
11.10.22	Illumina In Research Collaboration With AstraZeneca To Accelerate AI-based Drug Target Discovery (RTTNews)
22.09.22	Henry Ford Health First in Michigan to Offer Multi-Cancer Early Detection Blood Test (PR Newswire)
20.09.22	John Hancock becomes the first life insurance carrier to offer access to GRAIL's multi-cancer early detection test to customers (PR Newswire)
06.09.22	Illumina Plans To Appeal European Commission's Decision In Grail Deal (RTTNews)
02.09.22	U.S. Judge Rules In Favor Of Illumina In FTC Challenge Of GRAIL Deal (RTTNews)
12.08.22	Pre-market Movers: NEPT, OLO, LAW, CODX, LRMR… (RTTNews)
11.08.22	Illumina Cuts FY Forecast; Shares Tank 22% (RTTNews)
11.08.22	Illumina Inc. Q2 Earnings Summary (RTTNews)
13.07.22	General Court Dismisses Illumina's Plea Against Referral Request From France (RTTNews)
05.05.22	Illumina Inc. Q1 Profit Decreases, but beats estimates (RTTNews)
05.05.22	Form 10-Q 1110803 (RSS)
05.05.22	Form 8-K 1110803 (RSS)
02.05.22	Form 8-A12G 1110803 (RSS)
21.04.22	Form DEFR14A 1110803 (RSS)
21.04.22	Form 3 1110803 (RSS)
14.04.22	Form DEFA14A 1110803 (RSS)
14.04.22	Form DEF 14A 1110803 (RSS)
07.04.22	Form 4 1110803 (RSS)
30.03.22	Form 4 1110803 (RSS)
29.03.22	Form PRE 14A 1110803 (RSS)
24.02.22	Form 4 1110803 (RSS)
18.02.22	Form 10-K 1110803 (RSS)
15.02.22	GRAIL and Point32Health Collaborate to Offer Galleri® Multi-Cancer Early Detection Blood Test (PR Newswire)
10.02.22	Illumina Issues FY22 Outlook (RTTNews)
10.02.22	Illumina Inc. Q4 Profit Decreases, but beats estimates (RTTNews)
13.01.22	Form 4 1110803 (RSS)
11.01.22	Form 8-K 1110803 (RSS)
23.12.21	Form 4 1110803 (RSS)
21.12.21	Form SC TO-I/A 1110803 (RSS)
04.11.21	Illumina Revises FY Guidance (RTTNews)
04.11.21	Illumina Inc. Q3 adjusted earnings Beat Estimates (RTTNews)
07.09.21	Illumina Partners With Merck To Develop Tests For Use In Identifying Specific Cancer Mutations (RTTNews)
20.08.21	European Commission To Assess Illumina's Possible Breach Of Standstill Obligation (RTTNews)
18.08.21	Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test (PR Newswire)
05.08.21	Illumina Inc. Q2 adjusted earnings Beat Estimates (RTTNews)
05.08.21	Illumina Reports Financial Results for Second Quarter of Fiscal Year 2021 (PR Newswire)
04.08.21	Illumina Donates $1 Million in Sequencing Capabilities to Mumbai to Support Sequencing-Based COVID-19 Surveillance in India (PR Newswire)
01.06.21	Illumina Supports Nationwide Program across Belgium to Assess Whole Genome Sequencing for Developmental Disorders Diagnosis (Businesswire)
27.05.21	Illumina To Webcast Upcoming Investor Conference (Businesswire)
17.05.21	Illumina Appoints Susan Tousi as Chief Commercial Officer and Dr. Alex Aravanis as Chief Technology Officer, Head of Research and Product Development (Businesswire)
29.04.21	Illumina To Webcast Upcoming Investor Conference (Businesswire)
29.04.21	Illumina Files Action For Annulment Of EC's Decision Asserting Jurisdiction To Review GRAIL Deal (RTTNews)
29.04.21	Illumina Files Action for Annulment of European Commission’s Decision Asserting Jurisdiction to Review GRAIL Acquisition (Businesswire)
28.04.21	Illumina to Donate US $60 Million in Sequencing Capabilities to Establish a Global Pathogen Genomics Initiative (Businesswire)
27.04.21	Illumina Inc. Q1 adjusted earnings Beat Estimates (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

16.12.24		Handel in New York: NASDAQ 100 zeigt sich zum Start des Montagshandels fester
13.12.24		Gewinne in New York: NASDAQ 100 mittags mit grünem Vorzeichen
11.12.24		Aufschläge in New York: NASDAQ 100 am Mittwochmittag im Plus
11.12.24		Gute Stimmung in New York: NASDAQ 100 klettert zum Handelsstart
20.11.24		Mittwochshandel in New York: NASDAQ 100 liegt letztendlich im Minus
20.11.24		Schwacher Wochentag in New York: NASDAQ 100 in der Verlustzone
20.11.24		Schwacher Handel: NASDAQ 100 schwächelt mittags
20.11.24		Schwacher Wochentag in New York: NASDAQ 100 präsentiert sich zum Handelsstart schwächer

16.12.24

Handel in New York: NASDAQ 100 zeigt sich zum Start des Montagshandels fester

13.12.24

Gewinne in New York: NASDAQ 100 mittags mit grünem Vorzeichen

11.12.24

Aufschläge in New York: NASDAQ 100 am Mittwochmittag im Plus

11.12.24

Gute Stimmung in New York: NASDAQ 100 klettert zum Handelsstart

20.11.24

Mittwochshandel in New York: NASDAQ 100 liegt letztendlich im Minus

20.11.24

Schwacher Wochentag in New York: NASDAQ 100 in der Verlustzone